Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Fibromyalgia
San Diego, California–(Newsfile Corp. – November 2, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (” Tryp ” or the ” Company “), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today that it has submitted an Investigational New Drug (” IND “) application to the U.S. Food and Drug Administration (” FDA “) to evaluate its clinical […]
Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”), a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has entered into a definitive share purchase agreement (the “Definitive Agreement”), dated April 23, 2021, pursuant to which it will acquire all […]
Mydecine Innovations Group Graduates Listing To NEO Exchange
Growing biotech company becomes latest in a wave of migrations and graduations to NEO NEO is excited to announce that Mydecine Innovations Group (“Mydecine” or the “Company”), a psychedelics-inspired biotech and life sciences company, is now listed on the NEO Exchange, following a voluntary delisting from the Canadian Securities Exchange. Mydecine is now trading on NEO under the […]
